Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Zimmer Biomet's robust Knee business appears promising. However, a dull macroeconomic condition adds to the worry.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus rating of “Hold” from the twenty-two ...

Avantax Advisory Services Inc. lifted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 36.7% in the fourth quarter, according to its most recent 13F filing with the ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

Zimmer Biomet's ZBH fourth-quarter 2025 performance was driven by its market expansion efforts. The company’s robust Knee business looks promising for growth. Meanwhile, a dull macroeconomic ...

Stocks rallied Monday on reports over the weekend that said the upcoming US reciprocal tariffs next week would be more targeted than previously stated and narrower than initially planned, with some ...

Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical device company specializing in orthopedic solutions. With a ...

Detailed price information for Solventum Corporation (SOLV-N) from The Globe and Mail including charting and trades.

The stock's fall snapped a five-day winning streak.